LISINOPRIL/HCTZ (TYPE Z)
SANIS HEALTH INC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of LISINOPRIL/HCTZ (TYPE Z) in Canada?
A shortage of LISINOPRIL/HCTZ (TYPE Z) 20MG 12.5MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated August 18, 2026), but it has not started yet.
Why is LISINOPRIL/HCTZ (TYPE Z) not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will LISINOPRIL/HCTZ (TYPE Z) be available again?
No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.
DIN
02362953
Strength
20MG 12.5MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
LISINOPRIL HYDROCHLOROTHIAZIDE
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Other Products from SANIS HEALTH INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
200MG · DIN 02286254
400MG · DIN 02286262
100MG · DIN 02286246
400MG · DIN 02286564
70MG · DIN 02352966
10MG · DIN 02519844
12.5MG · DIN 02466821
0.50MG · DIN 02349205
0.25MG · DIN 02349191
200MG · DIN 02364336
10MG · DIN 02331292
5MG · DIN 02331284